The DEA has proposed a rule that requires anyone being prescribed certain controlled substances via telemedicine to see a doctor in person to continue their care online. It includes drugs like buprenorphine, used to treat people with opioid use disorder, testosterone therapy for transgender people, Adderall prescriptions for kids with ADHD, and other controlled medications. Patient responses to Boulder Care, a telehealth company, indicate that this new rule could jeopardize their health and lives. Many patients cannot travel to see a doctor, while others expressed fear of sharing their struggles with a local doctor in a small community.
Patients Fear New DEA Rule Requiring In-Person Visits Could Jeopardize Their Health